Cargando…
Discovery and characterization of the covalent SARS-CoV-2 3CL(pro) inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
BACKGROUND: The 3C-like proteases (3CL(pro)s) are cysteine-rich homodimeric proteins and can be covalently modified by numerous natural and synthetic compounds, which in turn, block the proteolytic activity or the formation of enzymatically active dimeric forms. Although herbal medicines have been w...
Autores principales: | Zhang, Ya-Ni, Zhu, Guang-Hao, Liu, Wei, Xiong, Yuan, Hu, Qing, Zhuang, Xiao-Yu, Jia, Gui-Hua, Zhang, Wei-Dong, Ge, Guang-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052880/ https://www.ncbi.nlm.nih.gov/pubmed/37037086 http://dx.doi.org/10.1016/j.phymed.2023.154796 |
Ejemplares similares
-
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL(pro) from Ginkgo biloba leaves via large-scale screening
por: Xiong, Yuan, et al.
Publicado: (2021) -
Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2
por: Song, Yun-Qing, et al.
Publicado: (2021) -
Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CL(pro): Inhibition potentials, covalent binding sites and inhibitory mechanisms
por: Xiong, Yuan, et al.
Publicado: (2021) -
Polyphenols from Ginkgo biloba
por: Qa’dan, Fadi, et al.
Publicado: (2010) -
Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1
por: Pang, Hui-Lin, et al.
Publicado: (2022)